Related Experiment Video
Updated: Jul 5, 2026

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres
Ji-Shan Quan1, Hu-Lin Jiang, Eun-Mi Kim
1Department of Agricultural Biotechnology, Seoul National University, Seoul 151-921, South Korea.
This study developed mucoadhesive, pH-sensitive chitosan microspheres coated with Eudragit-cysteine conjugate for oral protein delivery. The novel thiolated Eudragit-coated microspheres successfully protected and sustained the release of bovine serum albumin.
Area of Science:
- Pharmaceutical Sciences
- Biomaterials Science
- Drug Delivery Systems
Background:
- Oral protein delivery faces challenges due to enzymatic degradation and poor absorption.
- Chitosan microspheres (CMs) offer potential for drug delivery but require modifications for enhanced properties.
- Developing mucoadhesive and pH-sensitive systems is crucial for effective oral drug targeting.
Purpose of the Study:
- To develop an oral protein drug delivery system using Eudragit-cysteine conjugate-coated chitosan microspheres (CMs).
- To impart mucoadhesive and pH-sensitive properties to the chitosan microspheres for enhanced oral delivery.
- To evaluate the drug release characteristics and structural integrity of the model protein drug (bovine serum albumin - BSA).
Main Methods:
- Coating of chitosan microspheres with Eudragit-cysteine conjugate to form thiolated Eudragit-coated CMs (TECMs).
- Loading of bovine serum albumin (BSA) into TECMs and evaluation of its release profile at different pH levels (2.0 and 7.4).
- Assessment of BSA structural integrity using SDS-PAGE and CD spectroscopy.
- Evaluation of mucoadhesive properties using in vitro intestinal mucosa adhesion tests and in vivo gamma camera imaging in rats.
Main Results:
- BSA release from BSA-loaded TECMs was suppressed at pH 2.0 and sustained for hours at pH 7.4.
- The structural integrity of released BSA was confirmed by SDS-PAGE and CD spectroscopy.
- TECMs exhibited significantly higher mucoadhesion compared to CMs and Eudragit-coated CMs (ECMs), confirmed by in vitro and in vivo studies.
Conclusions:
- TECMs demonstrate effective mucoadhesive and pH-sensitive properties suitable for oral drug delivery.
- The developed system successfully protected and controlled the release of the model protein drug, BSA.
- TECMs show significant potential as carriers for oral protein drug delivery systems.
More Related Videos
05:26Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
12:22Synthesis of Thermogelling Poly(N-isopropylacrylamide)-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
Published on: October 26, 2016
Related Concept Videos
Oral Drug Delivery Systems: Delayed-Release Systems
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Modified-Release Drug Delivery Systems: Site-Targeted